Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 20-Nov-24 4:10 PM View:  | Warren Eric Chief Commercial Officer | Esperion Therapeutics, Inc. (ESPR) | 19-Nov-24 | Sale | 197 | $2.16 | $426.51 | (< 1%) 162.55K to 162.35K | |
| 18-Sep-24 4:12 PM View: | Koenig Sheldon L. President and CEO Director | Esperion Therapeutics, Inc. (ESPR) | 17-Sep-24 | Sale | 14,550 | $1.80 | $26,131.80 | (2%) 766.82K to 752.27K | |
| 18-Sep-24 4:11 PM View: | Warren Eric Chief Commercial Officer | Esperion Therapeutics, Inc. (ESPR) | 17-Sep-24 | Sale | 2,608 | $1.78 | $4,650.06 | (2%) 165.27K to 162.66K | |
| 20-Aug-24 4:03 PM View: | Warren Eric Chief Commercial Officer | Esperion Therapeutics, Inc. (ESPR) | 19-Aug-24 | Sale | 211 | $1.95 | $410.61 | (< 1%) 165.48K to 165.27K | |
| 19-Jul-24 8:30 AM View: | Warren Eric Chief Commercial Officer | Esperion Therapeutics, Inc. (ESPR) | 17-Jul-24 | Sale | 108 | $2.59 | $279.40 | (< 1%) 165.59K to 165.48K | |
| 19-Jul-24 8:29 AM View: | Foody Joanne M. Chief Medical Officer | Esperion Therapeutics, Inc. (ESPR) | 17-Jul-24 | Sale | 917 | $2.60 | $2,383.28 | (< 1%) 273.78K to 272.86K | |
| 20-Jun-24 4:20 PM View: | Foody Joanne M. Chief Medical Officer | Esperion Therapeutics, Inc. (ESPR) | 18-Jun-24 | Sale | 3,285 | $2.87 | $9,418.10 | (1%) 277.06K to 273.78K | |
| 20-Jun-24 4:16 PM View: | Warren Eric Chief Commercial Officer | Esperion Therapeutics, Inc. (ESPR) | 18-Jun-24 | Sale | 2,540 | $2.86 | $7,254.24 | (2%) 168.13K to 165.59K | |
| 24-May-24 4:18 PM View: | Fischer Seth H.Z. Director | Esperion Therapeutics, Inc. (ESPR) | 23-May-24 | Grant | 23,000 | -- | -- | 447% 5.15K to 28.15K | |
| 24-May-24 4:15 PM View: | Rocamboli Stephen Director | Esperion Therapeutics, Inc. (ESPR) | 23-May-24 | Grant | 23,000 | -- | -- | 173% 13.26K to 36.26K | |
| 24-May-24 4:17 PM View: | Fuhrman Alan Director | Esperion Therapeutics, Inc. (ESPR) | 23-May-24 | Grant | 23,000 | -- | -- | 76% 30.4K to 53.4K | |
| 24-May-24 4:16 PM View: | Gotto Antonio M Jr Md D Phil Director | Esperion Therapeutics, Inc. (ESPR) | 23-May-24 | Grant | 23,000 | -- | -- | 80% 28.6K to 51.6K | |
| 24-May-24 4:14 PM View: | Shepard Jay Director | Esperion Therapeutics, Inc. (ESPR) | 23-May-24 | Grant | 23,000 | -- | -- | 80% 28.6K to 51.6K | |
| 24-May-24 4:18 PM View: | Carroll J Martin Director | Esperion Therapeutics, Inc. (ESPR) | 23-May-24 | Grant | 23,000 | -- | -- | 55% 41.65K to 64.65K | |
| 20-May-24 4:14 PM View: | Warren Eric Chief Commercial Officer | Esperion Therapeutics, Inc. (ESPR) | 17-May-24 | Sale | 192 | $2.48 | $476.74 | (< 1%) 168.32K to 168.13K | |
| 15-Mar-24 4:32 PM View: | Halladay Benjamin Chief Financial Officer | Esperion Therapeutics, Inc. (ESPR) | 14-Mar-24 | Grant | 170,000 | -- | -- | 230% 73.94K to 243.94K | |
| 15-Mar-24 4:35 PM View: | Warren Eric Chief Commercial Officer | Esperion Therapeutics, Inc. (ESPR) | 14-Mar-24 | Grant | 100,000 | -- | -- | 146% 68.32K to 168.32K | |
| 15-Mar-24 10:00 PM View: | Koenig Sheldon L. President and CEO Director | Esperion Therapeutics, Inc. (ESPR) | 14-Mar-24 | Grant | 454,000 | -- | -- | 145% 312.82K to 766.82K | |
| 15-Mar-24 4:34 PM View: | Foody Joanne M. Chief Medical Officer | Esperion Therapeutics, Inc. (ESPR) | 14-Mar-24 | Grant | 150,000 | -- | -- | 118% 127.06K to 277.06K | |
| 15-Mar-24 4:33 PM View: | Looker Benjamin General Counsel | Esperion Therapeutics, Inc. (ESPR) | 14-Mar-24 | Grant | 100,000 | -- | -- | 120% 83.66K to 183.66K | |
| 21-Sep-23 5:06 PM View: | Warren Eric Chief Commercial Officer | Esperion Therapeutics, Inc. (ESPR) | 20-Sep-23 | Sale | 742 | $1.25 | $923.79 | (1%) 69.06K to 68.32K | |
| 21-Aug-23 4:32 PM View: | Warren Eric Chief Commercial Officer | Esperion Therapeutics, Inc. (ESPR) | 18-Aug-23 | Sale | 243 | $1.41 | $343.60 | (< 1%) 69.3K to 69.06K | |
| 20-Jul-23 4:38 PM View: | Warren Eric Chief Commercial Officer | Esperion Therapeutics, Inc. (ESPR) | 19-Jul-23 | Sale | 106 | $1.59 | $168.01 | (< 1%) 69.41K to 69.3K | |
| 22-Jun-23 4:45 PM View: | Warren Eric Chief Commercial Officer | Esperion Therapeutics, Inc. (ESPR) | 21-Jun-23 | Sale | 603 | $1.48 | $894.25 | (< 1%) 70.01K to 69.41K | |
| 16-Jun-23 4:09 PM View: | Woody Tracy M Director | Esperion Therapeutics, Inc. (ESPR) | 15-Jun-23 | Grant | 5,150 | -- | -- | 18% 28.42K to 33.57K | |
| 16-Jun-23 4:06 PM View: | Shepard Jay Director | Esperion Therapeutics, Inc. (ESPR) | 15-Jun-23 | Grant | 5,150 | -- | -- | 22% 23.45K to 28.6K | |
| 16-Jun-23 4:06 PM View: | Rocamboli Stephen Director | Esperion Therapeutics, Inc. (ESPR) | 15-Jun-23 | Grant | 5,150 | -- | -- | 63% 8.11K to 13.26K | |
| 16-Jun-23 4:07 PM View: | Vitullo Nicole Director | Esperion Therapeutics, Inc. (ESPR) | 15-Jun-23 | Grant | 5,150 | -- | -- | 16% 31.77K to 36.92K | |
| 16-Jun-23 4:08 PM View: | Fischer Seth H.Z. Director | Esperion Therapeutics, Inc. (ESPR) | 15-Jun-23 | Grant | 5,150 | -- | -- | 100% 0 to 5.15K | |
| 16-Jun-23 4:09 PM View: | Fuhrman Alan Director | Esperion Therapeutics, Inc. (ESPR) | 15-Jun-23 | Grant | 5,150 | -- | -- | 20% 25.25K to 30.4K | |
| 16-Jun-23 4:08 PM View: | Carroll J Martin Director | Esperion Therapeutics, Inc. (ESPR) | 15-Jun-23 | Grant | 5,150 | -- | -- | 14% 36.5K to 41.65K | |
| 16-Jun-23 4:05 PM View: | Gotto Antonio M Jr Md D Phil Director | Esperion Therapeutics, Inc. (ESPR) | 15-Jun-23 | Grant | 5,150 | -- | -- | 22% 23.45K to 28.6K | |
| 18-May-23 4:07 PM View: | Warren Eric Chief Commercial Officer | Esperion Therapeutics, Inc. (ESPR) | 17-May-23 | Sale | 219 | $1.62 | $355.66 | (< 1%) 70.23K to 70.01K | |
| 11-May-23 4:11 PM View: | Carroll J Martin Director | Esperion Therapeutics, Inc. (ESPR) | 11-May-23 | Purchase | 23,091 | $1.57 | $36,285.20 | 172% 13.41K to 36.5K | |
| 11-May-23 4:11 PM View: | Carroll J Martin Director | Esperion Therapeutics, Inc. (ESPR) | 10-May-23 | Private Purchase | 8,409 | $1.49 | $12,545.40 | 168% 5.0K to 13.41K | |
| 11-May-23 4:10 PM View: | Rocamboli Stephen Director | Esperion Therapeutics, Inc. (ESPR) | 10-May-23 | Private Purchase | 8,111 | $1.50 | $12,125.90 | 100% 0 to 8.11K | |
| 10-May-23 4:12 PM View: | Koenig Sheldon L. President and CEO Director | Esperion Therapeutics, Inc. (ESPR) | 09-May-23 | Private Purchase | 20,000 | $1.26 | $25,192.00 | 7% 292.82K to 312.82K | |
| 20-Apr-23 4:12 PM View: | Warren Eric Chief Commercial Officer | Esperion Therapeutics, Inc. (ESPR) | 19-Apr-23 | Sale | 115 | $1.28 | $146.97 | (< 1%) 70.35K to 70.23K | |
| 20-Apr-23 4:11 PM View: | Foody Joanne M. Chief Medical Officer | Esperion Therapeutics, Inc. (ESPR) | 19-Apr-23 | Sale | 938 | $1.27 | $1,192.20 | (< 1%) 128.0K to 127.06K | |
| 20-Apr-23 4:12 PM View: | Looker Benjamin General Counsel | Esperion Therapeutics, Inc. (ESPR) | 19-Apr-23 | Sale | 1,290 | $1.27 | $1,640.88 | (2%) 84.95K to 83.66K | |
| 20-Mar-23 4:19 PM View: | Foody Joanne M. Chief Medical Officer | Esperion Therapeutics, Inc. (ESPR) | 17-Mar-23 | Sale | 3,808 | $1.78 | $6,785.48 | (3%) 131.81K to 128.0K | |
| 20-Mar-23 4:16 PM View: | Koenig Sheldon L. President and CEO Director | Esperion Therapeutics, Inc. (ESPR) | 17-Mar-23 | Sale | 6,999 | $1.78 | $12,479.20 | (2%) 299.81K to 292.82K | |
| 20-Mar-23 4:16 PM View: | Warren Eric Chief Commercial Officer | Esperion Therapeutics, Inc. (ESPR) | 17-Mar-23 | Sale | 526 | $1.78 | $937.49 | (< 1%) 70.87K to 70.35K | |
| 15-Mar-23 9:22 AM View: | Warren Eric Chief Commercial Officer | Esperion Therapeutics, Inc. (ESPR) | 14-Mar-23 | Grant | 22,300 | -- | -- | 46% 48.57K to 70.87K | |
| 15-Mar-23 9:20 AM View: | Foody Joanne M. Chief Medical Officer | Esperion Therapeutics, Inc. (ESPR) | 14-Mar-23 | Grant | 28,750 | -- | -- | 28% 103.06K to 131.81K | |
| 15-Mar-23 9:21 AM View: | Koenig Sheldon L. President and CEO Director | Esperion Therapeutics, Inc. (ESPR) | 14-Mar-23 | Grant | 105,000 | -- | -- | 54% 194.81K to 299.81K | |
| 15-Mar-23 9:21 AM View: | Halladay Benjamin Chief Financial Officer | Esperion Therapeutics, Inc. (ESPR) | 14-Mar-23 | Grant | 9,200 | -- | -- | 14% 64.74K to 73.94K | |
| 15-Mar-23 9:23 AM View: | Looker Benjamin General Counsel | Esperion Therapeutics, Inc. (ESPR) | 14-Mar-23 | Grant | 20,500 | -- | -- | 32% 64.45K to 84.95K | |
| 08-Mar-23 4:21 PM View: | Koenig Sheldon L. President and CEO Director | Esperion Therapeutics, Inc. (ESPR) | 07-Mar-23 | Private Sale | 5,441 | $5.06 | $27,509.70 | (3%) 200.26K to 194.81K | |
| 08-Mar-23 4:22 PM View: | Warren Eric Chief Commercial Officer | Esperion Therapeutics, Inc. (ESPR) | 07-Mar-23 | Private Sale | 5,090 | $5.05 | $25,729.90 | (9%) 53.66K to 48.57K |
